Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Serum C peptide and carotid intima-medial thickness are independent markers of glucose intolerance among patients with ischemic cerebrovascular stroke

The Egyptian Journal of Internal Medicine volume 31, pages 368–375 (2019)Cite this article

En

Abstract

Background

Stroke is the most common cause of disability worldwide. C-peptide is co-secreted with insulin from beta cells of the pancreas, thus providing a better index of endogenous insulin production and pancreatic beta cell function. The objective of the current study was to explore serum C-peptide and carotid intimamedia thickness in patients with ischemic stroke (IS) and to assess the association of serum C-peptide with vascular and metabolic risks.

Patients and methods

The case–control study included 50 healthy control and 150 patients with IS who were stratified into three subgroups according to their fasting plasma glucose, normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and type 2 diabetes mellitus (T2DM). All the participants were subjected to B-mode ultrasonography of both common carotid arteries to measure carotid intimamedia thickness (mm). Serum C peptide concentration was measured by enzyme-linked immunosorbent assay.

Results

Serum C peptide levels were higher in IS patients compared with control. Among the IS patients, C peptide was higher in T2DM compared with IGT and NGT and is associated with vascular and metabolic risks, after adjusting for the traditional risk factors. C-peptide was a statistically significance predictor of T2DM among IS patients by the logistic regression analysis test. In addition, homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose, BMI, and fat mass index (FMI)% were independently correlated with C-peptide by. The diagnostic value of C-peptide by receiver operating characteristic curves was highly significant; the sensitivities and the specificities were 96 and 98%.

Conclusion

Serum peptide levels were higher in IS patients compared with the control. Among the IS patients, serum C peptide was higher in T2DM compared with IGT and NGT and is associated with vascular and metabolic risks.

References

  1. Bunevicius A, Iervasi G, Bunevicius R, Appel LJ, Braun LT, Chaturvedi S et al. Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother 2015; 15: 315–326.

    Article  CAS  Google Scholar 

  2. Goldstein LB, Bushnell CD, Adams RJ et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517–584.

    Article  Google Scholar 

  3. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJM, Holman RR. UKPDS 59: Hyperglycemia b and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002; 25: 894–899.

    Article  Google Scholar 

  4. International Diabetes Federation Diabetes Atlas. Diabetes care (2nd ed.). International Diabetes Federation: Brussels. 2003.

    Google Scholar 

  5. Held C, Hjemdahl P, Eriksson SV, Björkander I, Forslund L, Rehngvist N. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J 2001; 22: 62–72.

    Article  CAS  Google Scholar 

  6. Acevedo M, Krämer V, Tagle R, Arnaiz P, Corbalán R, BerrÃos X et al. Cardiovascular risk factors among young subjects with high carotid intima-media thickness. Rev Med Chil 2011; 139: 1322–1329.

    Article  Google Scholar 

  7. Ferranini E, Cobelli C. The kinetics of insulin in man. Role Liver Diabetes Metab Rev 1987; 3: 365–397.

    Article  Google Scholar 

  8. Ashby TD, Frier BM. Circulating c-peptide measurement and clinical application. Annals Clin Biochem 1981; 18: 125.

    Article  CAS  Google Scholar 

  9. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic amino acids. Lancet 1997; 349: 79–83.

    Article  CAS  Google Scholar 

  10. Frieldewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    Article  Google Scholar 

  11. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV et al. A randomized trial of intensive versus standard blood pressure control. N Engl J Med 2015; 373:2103–2116.

    Article  CAS  Google Scholar 

  12. Tardif JC, Heinonen T, Orloff D, Libby P. Vascular biomarkers and surrogates in cardiovascular disease. Circulation 2006; 113: 2936–2942.

    Article  Google Scholar 

  13. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima‐media thickness: a systematic review and meta‐analysis. Circulation 2007; 115: 459–467.

    Article  Google Scholar 

  14. De Groot E, van Leuven SI, Duivenvoorden R, Meuwese MC, Akdim F et al. Measurement of carotid intima‐media thickness to assess the progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 2008; 5: 280–288.

    Article  Google Scholar 

  15. Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, Volzke H, Bots ML et al. PROG‐IMT Study Group. Carotid intima‐media thickness progression to predict cardiovascular events in the general population (the PROG‐IMT collaborative project): a meta‐analysis of individual participant data. Lancet 2012; 379: 2053–2062.

    Article  Google Scholar 

  16. Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann XX et al. Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk — Results from the PROG-IMT collaboration. PLoS One 2018; 13: e0191172.

    Article  Google Scholar 

  17. Li Y, Meng L, Li Y, Sato Y. Associations of serum C-Peptide level with body fat distribution and ever stroke in nondiabetic subjects. J Stroke Cerebrovasc Dis 2014; 23: e163–e169.

    Article  Google Scholar 

  18. Hirai FE, Moss SE, Klein BE et al. Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR). Diabetes Care 2008; 31: 493–497.

    Article  CAS  Google Scholar 

  19. Marx N, Silbernagel G, Brandenburg V et al. C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC Study. Diabetes Care 2013; 36: 708–714.

    Article  CAS  Google Scholar 

  20. Walcher D, Aleksic M, Jerg V, Burgmaier M, Kleber M, Grammer T et al. C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 2004; 53: 1664–1670.

    Article  CAS  Google Scholar 

  21. Marx N, Walcher D, Raichle C, Aleksic M, Bach H, Grüb M et al. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 2004; 24: 540–545.

    Article  CAS  Google Scholar 

  22. Walcher D, Babiak C, Poletek P, Hombach V, Zieske A, Homma S et al. C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res 2006; 99: 1181–1187.

    Article  CAS  Google Scholar 

  23. Haban P, Simoncic R, Zidekova E, Ozdin L. Role of fasting serum C-peptide as a predictor of cardiovascular risk associated with the metabolic X-syndrome. Med Sci Monit 2002; 8: CR175–CR179.

    CAS  PubMed  Google Scholar 

  24. Kim ST, Kim BJ, Lim DM, Song I, Jung J, Lee K et al. Basal C-peptide level as a surrogate marker of subclinical atherosclerosis in type 2 diabetic patients. Diabetes Metab J 2011; 35: 41–49.

    Article  Google Scholar 

  25. Wang L, Lin P, Ma A, Zheng H, Wang K, Li W et al. C-peptide is independently associated with an increased risk of coronary artery disease in T2DM subjects: a cross-sectional study. PLoS One 2015; 10: e0127112.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt, 44519

    Nearmeen M. Rashad MD & Ghada M. Samir

  2. Department of Neurology, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Hanan M. Sabry

  3. Department of Radiodiagnosis, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Nesreen M. Mohy

  4. Department of Medical Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Shereen M. El Shabrawy

Authors
  1. Nearmeen M. Rashad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ghada M. Samir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanan M. Sabry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nesreen M. Mohy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shereen M. El Shabrawy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nearmeen M. Rashad MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Financial support and sponsorship

Nil.

Conflicts of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rashad, N.M., Samir, G.M., Sabry, H.M. et al. Serum C peptide and carotid intima-medial thickness are independent markers of glucose intolerance among patients with ischemic cerebrovascular stroke. Egypt J Intern Med 31, 368–375 (2019). https://doi.org/10.4103/ejim.ejim_97_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_97_18

Keywords